It is tempting to speculate that overexpression of APP, which leads to neurodegeneration in Alzheimer’s disease (reviewed in (Hardy and Selkoe, 2002)), may occur in FXS. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.